• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在细针穿刺标本中,是否存在可以预测甲状腺乳头状癌 BRAF 突变状态的特定细胞学特征?

Are there specific cytologic features that can predict BRAF mutational status of papillary thyroid carcinoma in fine-needle aspiration specimens?

机构信息

Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Diagn Cytopathol. 2024 Jun;52(6):295-302. doi: 10.1002/dc.25290. Epub 2024 Feb 19.

DOI:10.1002/dc.25290
PMID:38372437
Abstract

BACKGROUND

BRAF mutation is the most common molecular alteration found in papillary thyroid carcinoma (PTC) and has been linked to recurrent disease or possibly more aggressive behavior. Some studies have reported sickle-shaped nuclei (SSN) and plump pink cells (PPC) to be predictive markers of BRAF mutation in FNA cytology. We aimed to evaluate the reproducibility of the aforementioned cytologic features.

METHODS

A computerized search for diagnosed PTC surgical pathology cases tested for BRAF mutation by Sanger DNA sequencing was performed. Blinded to BRAF results, the corresponding cytology was reviewed for presence of SSN and PPC. Classic nuclear PTC (CNPTC) features, cystic change, and psammoma bodies were also evaluated. The results were correlated with BRAF mutational status and histologic subtypes.

RESULTS

Study cohort consisted of 113 cases (74 BRAF mutated, 39 BRAF wild type). SSN and combined CNPTC /SSN had positive predictive value of 74% and 75%, respectively. CNPTC showed 92% sensitivity and 20% specificity. Psammoma bodies had 92% specificity and 5% sensitivity. The presence of combined PPC/SSN showed 80% specificity, 27% sensitivity, and diagnostic accuracy of 45%. CNPTC was seen in 60/61 (98%) SSN and 45/45 (100%) PPC. There was no significant statistical association between SSN, PPC, and CNPTC with specific histologic subtypes and BRAF mutational status.

CONCLUSION

CNPTC is sensitive but not specific for BRAF mutational status. SSN, PPC, and CNPTC are not predictive markers for the presence of BRAF mutation or histologic subtypes. Additional studies may be needed to further corroborate these findings.

摘要

背景

BRAF 突变是甲状腺乳头状癌(PTC)中最常见的分子改变,与复发性疾病或可能更具侵袭性的行为有关。一些研究报告称,镰状核(SSN)和圆润的粉红色细胞(PPC)是 FNA 细胞学中 BRAF 突变的预测标志物。我们旨在评估上述细胞学特征的可重复性。

方法

通过 Sanger DNA 测序对诊断为 PTC 手术病理病例进行 BRAF 突变检测,对计算机检索进行。在不了解 BRAF 结果的情况下,对相应的细胞学进行 SSN 和 PPC 的存在进行审查。还评估了经典核 PTC(CNPTC)特征、囊性变和砂粒体。结果与 BRAF 突变状态和组织学亚型相关。

结果

研究队列包括 113 例(74 例 BRAF 突变,39 例 BRAF 野生型)。SSN 和合并的 CNPTC/SSN 的阳性预测值分别为 74%和 75%。CNPTC 的敏感性为 92%,特异性为 20%。砂粒体的特异性为 92%,敏感性为 5%。联合 PPC/SSN 的存在具有 80%的特异性、27%的敏感性和 45%的诊断准确性。61 例 SSN 中可见 CNPTC(98%),45 例 PPC 中可见 CNPTC(100%)。SSN、PPC 和 CNPTC 与特定组织学亚型和 BRAF 突变状态之间没有显著的统计学关联。

结论

CNPTC 对 BRAF 突变状态敏感,但特异性不高。SSN、PPC 和 CNPTC 不是 BRAF 突变或组织学亚型存在的预测标志物。可能需要进一步的研究来进一步证实这些发现。

相似文献

1
Are there specific cytologic features that can predict BRAF mutational status of papillary thyroid carcinoma in fine-needle aspiration specimens?在细针穿刺标本中,是否存在可以预测甲状腺乳头状癌 BRAF 突变状态的特定细胞学特征?
Diagn Cytopathol. 2024 Jun;52(6):295-302. doi: 10.1002/dc.25290. Epub 2024 Feb 19.
2
Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.中国湘南地区一家三级医院的回顾性研究:BRAF V600E 分子检测和甲状腺细针抽吸细胞学诊断价值及挑战
Acta Cytol. 2023;67(6):629-638. doi: 10.1159/000534138. Epub 2023 Sep 14.
3
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.细针抽吸细胞学检查甲状腺乳头状癌时 BRAF V600E 基因突变呈假阴性。
World J Surg Oncol. 2017 Nov 13;15(1):202. doi: 10.1186/s12957-017-1266-5.
4
Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience.甲状腺细针穿刺细胞学检查中能够预测BRAF(V600E)突变恶性肿瘤的形态学参数:我们机构的经验
Cancer Cytopathol. 2014 Dec;122(12):883-91. doi: 10.1002/cncy.21475. Epub 2014 Aug 25.
5
The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?细针穿刺抽吸(FNA)与 BRAF V600E 基因检测联合应用:是否能提高甲状腺乳头状癌 Bethesda III 类结节的明确诊断率?
Am Surg. 2024 Dec;90(12):3209-3215. doi: 10.1177/00031348241265143. Epub 2024 Jul 24.
6
The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF mutation.甲状腺癌中单羧酸转运体的表达可能与BRAF突变的形态学特征相关。
Endocrine. 2017 May;56(2):379-387. doi: 10.1007/s12020-016-1044-0. Epub 2016 Aug 2.
7
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.甲状腺乳头状癌滤泡变体中罕见的BRAF突变:新见解
Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586. Epub 2015 Jul 31.
8
Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.甲状腺结节细针穿刺标本中BRAFV600E突变的检测可优化细胞病理学诊断,尤其是在BRAF600E突变高发地区。
Clin Endocrinol (Oxf). 2006 Nov;65(5):660-6. doi: 10.1111/j.1365-2265.2006.02646.x.
9
Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.利用甲状腺乳头状癌残留的常规细针穿刺标本检测BRAF基因c.1799T > A(p.V600E)突变
Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302. Epub 2015 Jul 7.
10
Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.在 BRAF V600E 突变高发地区,对 4585 例连续病例进行三种分子检测方法的比较分析:高敏感检测甲状腺结节细针穿刺标本中 BRAF V600E 突变的临床意义。
J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12.

引用本文的文献

1
Deep convolutional neural network model ResNeSt for discrimination of papillary thyroid carcinomas and benign nodules in thyroid nodules diagnosed as atypia of undetermined significance.用于鉴别诊断为意义不明确的非典型性甲状腺结节中的甲状腺乳头状癌和良性结节的深度卷积神经网络模型ResNeSt
Gland Surg. 2024 May 30;13(5):619-629. doi: 10.21037/gs-23-486. Epub 2024 May 27.